As shown by methylation-specific PCR, all of diffuse astrocytomas had unmethylated SFRP1 promoter, while 16.7% of anaplastic and 53.9% of glioblastomas had methylated promoter. The gene discussed is SFRP1; the disease is glioblastoma.